没花的是打扰
发表于 2025-3-27 00:57:14
https://doi.org/10.1007/978-90-313-9647-4f early stage tumours is likely to increase following greater implementation in screening programs. The goal of this invited review is to provide recommendations based on the consensus discussion on the information from preoperative imaging that is of relevance for clinical decision-making for patients with early rectal cancer.
expound
发表于 2025-3-27 03:45:56
http://reply.papertrans.cn/31/3008/300729/300729_32.png
名义上
发表于 2025-3-27 07:55:33
Book 2014 well as colorectal cancer with synchronous resectable liver metastases. The contents comprise the majority of the invited contributions from the Second St. Gallen EORTC Gastrointestinal Cancer Conference, held on 6-8 March 2014 in St. Gallen, Switzerland. Written by some of the world’s leading expe
misanthrope
发表于 2025-3-27 12:38:09
http://reply.papertrans.cn/31/3008/300729/300729_34.png
octogenarian
发表于 2025-3-27 17:27:38
http://reply.papertrans.cn/31/3008/300729/300729_35.png
移动
发表于 2025-3-27 18:23:59
http://reply.papertrans.cn/31/3008/300729/300729_36.png
黄油没有
发表于 2025-3-27 22:03:28
http://reply.papertrans.cn/31/3008/300729/300729_37.png
Axon895
发表于 2025-3-28 03:57:53
https://doi.org/10.1007/978-3-662-24753-2erative outcomes and similar oncologic results. However, the conversion rate of LTME is around 17 %. The literature supporting RTME is more limited. Robotic rectal resection appears to have similar postoperative and oncologic outcomes compared to LTME. RTME results in higher costs and possibly lower
otic-capsule
发表于 2025-3-28 07:30:32
https://doi.org/10.1007/978-3-7091-5380-2lled surgery in terms of total mesorectal excision (TME) in the trial setting can be associated with much lower local recurrence rates of less than 10 % whether patients receive radiotherapy or not. Because of the high risk of metastatic disease in selected patients, integrating more active chemothe
Soliloquy
发表于 2025-3-28 12:04:14
,Arbeitsplan und Bauart der Versuchskörper,oadjuvant therapy (50 %). The most frequently used instruments were the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (QLQ-C30), its colorectal cancer specific module QLQ-CR38, and the Medical Outcomes Study Short-Form 36 items questionnaire. Findin